Halozyme Therapeutics
HALOHalozyme Therapeutics is a U.S. biotechnology company that develops novel oncology therapies designed to target the tumor microenvironment and licenses a novel drug delivery technology through corporate partnerships. The company was founded in 1998 and went public in 2004. Halozyme is headquartered …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Halozyme Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 10/3/2025 | Sell | Torley, Helen | PRESIDENT AND CEO | $70.1 | $1,380,638 |
| 10/2/2025 | Sell | Torley, Helen | PRESIDENT AND CEO | $72.4 | $1,424,083 |
| 10/1/2025 | Sell | Torley, Helen | PRESIDENT AND CEO | $75.4 | $1,507,024 |
| 10/1/2025 | Sell | Connaughton, Bernadette | Director | $75.4 | $150,481 |
| 9/22/2025 | Sell | Labrosse, Nicole | SVP, CHIEF FINANCIAL OFFICER | $78.3 | $173,584 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)